Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials (Q21203067)

17 August 2022

4

Sameline Grimsgaard

Sameline

Grimsgaard

1 reference

17 August 2022

5

Terje Alraek

Terje

Alraek

1 reference

17 August 2022

Jianping Liu

1

Jianping

Liu

1 reference

17 August 2022

Jing Zhang

series ordinal

2

author given names

Jing

author last names

Zhang

1 reference

17 August 2022

Yi Shi

series ordinal

3

author given names

Yi

author last names

Shi

1 reference

https://scigraph.springernature.com/pub.10.1186/1749-8546-1-4

17 August 2022

language of work or name

English

0 references

publication date

2006

0 references

published in

Chinese Medicine

0 references

volume

1

0 references

page(s)

4

0 references

issue

1

0 references

exact match

0 references

cites work

Measuring inconsistency in meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Safety of statins: focus on clinical pharmacokinetics and drug interactions

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Statins for Everybody? New Evidence on the Efficacy and Safety of the Inhibitors of HMG Co-A Reductase

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

A safety look at currently available statins

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Herbs for serum cholesterol reduction: a systematic view.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Medical management of hyperlipidemia/dyslipidemia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Do certain countries produce only positive results? A systematic review of controlled trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Clinical observation on effect of taizhi'an capsule in treating 150 patients with hyperlipidemia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Constituents of red yeast rice, a traditional Chinese food and medicine

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761143

Monograph. Monascus purpureus (red yeast rice)

29 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17302963

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17302963

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Effect of xuezhikang on the treatment of primary hyperlipidemia]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17302963

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1749-8546-1-4

1 reference

2402444

0 references

2402444

1 reference

1 reference

1 reference